Connection

Dev Arya to Ligands

This is a "connection" page, showing publications Dev Arya has written about Ligands.
Connection Strength

0.999
  1. A fluorescent aminosugar to rapidly screen and study RNA binders. Methods Enzymol. 2019; 623:291-314.
    View in: PubMed
    Score: 0.148
  2. Linker dependent intercalation of bisbenzimidazole-aminosugars in an RNA duplex; selectivity in RNA vs. DNA binding. Bioorg Med Chem Lett. 2016 12 15; 26(24):5989-5994.
    View in: PubMed
    Score: 0.123
  3. Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold. Org Biomol Chem. 2016 Feb 14; 14(6):2052-6.
    View in: PubMed
    Score: 0.118
  4. An assay for human telomeric G-quadruplex DNA binding drugs. Bioorg Med Chem Lett. 2013 Dec 15; 23(24):6695-9.
    View in: PubMed
    Score: 0.100
  5. Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates. Bioorg Med Chem Lett. 2013 Oct 15; 23(20):5689-93.
    View in: PubMed
    Score: 0.099
  6. Dual recognition of the human telomeric G-quadruplex by a neomycin-anthraquinone conjugate. Chem Commun (Camb). 2013 Jun 28; 49(51):5796-8.
    View in: PubMed
    Score: 0.098
  7. Recognition of HIV TAR RNA by triazole linked neomycin dimers. Bioorg Med Chem Lett. 2011 Aug 15; 21(16):4788-92.
    View in: PubMed
    Score: 0.085
  8. Aminoglycoside binding to Oxytricha nova telomeric DNA. Biochemistry. 2010 Nov 16; 49(45):9891-903.
    View in: PubMed
    Score: 0.081
  9. Triple recognition of B-DNA by a neomycin-Hoechst 33258-pyrene conjugate. Biochemistry. 2010 Jan 26; 49(3):452-69.
    View in: PubMed
    Score: 0.077
  10. Recognition of the unique structure of DNA:RNA hybrids. Biochimie. 2008 Jul; 90(7):1026-39.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.